Hepatic veno-occlusive disease with immunodeficiency (VODI): first reported case in the U.S. and identification of a unique mutation in Sp110
- PMID: 22982295
- DOI: 10.1016/j.clim.2012.07.016
Hepatic veno-occlusive disease with immunodeficiency (VODI): first reported case in the U.S. and identification of a unique mutation in Sp110
Abstract
Familial hepatic veno-occlusive disease with immunodeficiency (VODI, OMIM: 235550), a rare form of severe combined immune deficiency, was first described in Australian Lebanese patients as being associated with homozygous mutations in SP110, a gene encoding a PML nuclear body-associated protein. We present the first case of confirmed VODI in the United States, and identify the first novel missense mutation in SP110. The 3-year-old daughter of Hispanic parents without known consanguinity presented at age 5 months with fever, hepatomegaly, and pancytopenia. Her brother died at age 3 months from hepatic failure of undetermined etiology. Initial T- and B-cell counts were low, but eventually normalized. Serum IgG and IgM levels were low for age. Lymphoproliferation to mitogens and allogenic B-cells was normal, but absent to tetanus and candida antigens. Serum antibody levels against pneumococcal, Hib and tetanus antigens were low. Liver biopsies at ages 5 and 9 months were consistent with hepatic veno-occlusive disease or hVOD (also known as sinusoidal obstruction syndrome or SOS) and broncho-alveolar lavage detected Pneumocystis jiroveci. The patient recovered from her acute disease and has been clinically stable on immunoglobulin replacement therapy and trimethoprim-sulfamethoxazole prophylaxis. T-Cell receptor excision circle (TREC) analysis suggests that VODI will not be detected by newborn screening for severe combined immunodeficiency that relies on this assay. DNA was obtained from the patient, 4 siblings, and both parents, and SP110 was sequenced. The first missense mutation, a homozygous deletion/insertion variation in exon 2 (NM_080424.2 (SP110):c.78_79delinsAT) was detected in the patient. This novel mutation segregated in the heterozygous state in other living unaffected family members. The mechanism by which this SP110 mutation associates with VODI is consistent with the normal length mutated SP110 protein being subject to enhanced proteosome degradation resulting in marked reductions in SP110 protein.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome.J Allergy Clin Immunol. 2012 Sep;130(3):735-742.e6. doi: 10.1016/j.jaci.2012.02.054. Epub 2012 May 21. J Allergy Clin Immunol. 2012. PMID: 22621957
-
Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease.Nat Genet. 2006 Jun;38(6):620-2. doi: 10.1038/ng1780. Epub 2006 Apr 30. Nat Genet. 2006. PMID: 16648851
-
The first prenatal diagnosis for veno-occlusive disease and immunodeficiency syndrome, an autosomal recessive condition associated with mutations in SP110.Prenat Diagn. 2007 Jul;27(7):674-6. doi: 10.1002/pd.1759. Prenat Diagn. 2007. PMID: 17510920
-
Pneumocystis pneumonia.Semin Respir Crit Care Med. 2011 Dec;32(6):775-82. doi: 10.1055/s-0031-1295725. Epub 2011 Dec 13. Semin Respir Crit Care Med. 2011. PMID: 22167405 Review.
-
Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.Nephrology (Carlton). 2013 Nov;18(11):736-42. doi: 10.1111/nep.12133. Nephrology (Carlton). 2013. PMID: 24571744 Review.
Cited by
-
Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection.J Fungi (Basel). 2023 Jul 31;9(8):812. doi: 10.3390/jof9080812. J Fungi (Basel). 2023. PMID: 37623583 Free PMC article. Review.
-
Host transcription factor Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence.J Biol Chem. 2017 Dec 15;292(50):20379-20393. doi: 10.1074/jbc.M117.796839. Epub 2017 Oct 18. J Biol Chem. 2017. PMID: 29046350 Free PMC article.
-
Molecular Classification of Primary Immunodeficiencies of T Lymphocytes.Adv Immunol. 2018;138:99-193. doi: 10.1016/bs.ai.2018.02.003. Epub 2018 Mar 29. Adv Immunol. 2018. PMID: 29731008 Free PMC article. Review.
-
Expression Data Analysis for the Identification of Potential Biomarker of Pregnancy Associated Breast Cancer.Pathol Oncol Res. 2017 Jul;23(3):537-544. doi: 10.1007/s12253-016-0133-y. Epub 2016 Nov 10. Pathol Oncol Res. 2017. PMID: 27832451
-
Preventive Effect of the Herbal Preparation, HemoHIM, on Cisplatin-Induced Immune Suppression.Evid Based Complement Alternat Med. 2019 Mar 20;2019:3494806. doi: 10.1155/2019/3494806. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31015850 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources